Patents
Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
05/2000
05/16/2000US6063847 Thrombin receptor antagonists
05/16/2000US6063809 Anti-first-pass effect compounds
05/16/2000US6063360 Free radicals comprising benzodithiole derivatives
05/16/2000US6063181 1,7-disubstituted perylene-3,4,9, 10-tetracarboxylic acids, their dianhydrides and diimides of said acids
05/11/2000WO2000026037A1 Heat sensitive recording material
05/10/2000EP0998471A1 Substituted heterocyclic compounds, method for preparing and compositions containing same
05/10/2000EP0762879B1 Stereochemical wortmannin derivatives
05/10/2000EP0649533B1 Reagents and methods for the detection and quantification of thyroxine in fluid samples
05/10/2000CN1252719A Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment
05/10/2000CN1052236C Process for prepn. of ivermectin
05/09/2000CA2084412C Pyrrolidine and thiazolidine amides
05/09/2000CA2077660C Isomerization of epoxyalkenes to 2,5-dihydrofurans and catalysts compositions useful therefor
05/09/2000CA1340989C Chemiluminescent 1, 2-dioxetane compounds
05/04/2000WO2000024736A1 Oxobenzofuranylide-dihydroindolone
05/04/2000WO1999063988A9 Inhibitors of nitric oxide synthase
05/03/2000EP0996619A1 Tropane analogs and methods for inhibition of monoamine transport
05/03/2000EP0996441A1 Pharmaceutical compositions of arglabin and arglabin derivatives
05/03/2000EP0996434A1 Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
05/03/2000CN1052075C Optical lens containing transparent resins with high hardness
05/03/2000CN1052006C Vasocontrictive dihydrobenzopyran derivatives, preparation and use thereof
05/03/2000CN1052002C 4-aryl-4-hydroxy-tetrahydropyrans and 3-aryl-3-hydroxy-tetrahydrofurans, preparation thereof and medicinal composition comprising them
05/03/2000CN1051995C Preparation of polymerizable monomer used for transparent resin having high hardness
05/03/2000CN1051982C Glazing material comprising high-hard transparent resin
05/02/2000US6057460 Monomers for acrylates, vinyl, allyl, ether, epoxy or styryl
05/02/2000US6057441 Cardiovascular disorders and gastrointestinal disorders
05/02/2000CA2000179C Cyclopenteneheptenoic acid derivatives and method of preparation thereof
04/2000
04/27/2000WO2000023452A1 Method for producing epothilone b and derivatives, and intermediate products for this method
04/27/2000WO2000023445A1 New compounds, their preparation and use
04/27/2000WO2000023433A1 Substituted benzopyran analogs for the treatment of inflammation
04/27/2000WO2000023059A2 Use of anticonvulsant derivatives for treating alcohol dependency
04/27/2000CA2347910A1 Substituted benzopyran analogs for the treatment of inflammation
04/27/2000CA2346493A1 Method for producing epothilone b and derivatives, and intermediate products for this method
04/25/2000US6054477 Anti-first-pass effect compounds
04/25/2000US6054475 Substituted dihydrobenzofuran-based phosphodiesterase 4 inhibitors useful for treating airway disorders
04/25/2000US6054449 Photodynamic therapy
04/20/2000WO2000021946A1 3-phenyl-pyrones
04/20/2000WO2000006525A9 Synthesis of combinatorial libraries of compounds reminiscent of natural products
04/20/2000WO2000004023A9 Anhydride modified cantharidin analogues useful in the treatment of cancer
04/20/2000WO1999067253A3 Desmethyl epothilones
04/20/2000WO1999065913A3 Epothilone minor constituents
04/20/2000DE19848306A1 High yield preparation of cytotoxic or fungicidal compound epothilon B, from phenylsulfonyl-butanol derivative by multistage process via new thiazole derivative intermediates
04/20/2000DE19846517A1 New 3-phenyl-4-hydroxy-2-pyrone derivatives useful as pesticides, herbicides and fungicides
04/19/2000EP0994102A1 Cyclic derivatives with a cycloalkylenic chain, process for their preparation and pharmaceutical compositions containing them
04/19/2000EP0993462A1 Calixarene tubes as cation receptors
04/19/2000CN1250778A Novel monomer and its polymer used for anti-photoetching agent, and their compositions
04/19/2000CN1250771A Novel cyclocompound having cycloalkylene chain, prepn. method and pharmaceutical compositions contg. same
04/18/2000US6051723 3-aryl-tetronic acid derivatives
04/18/2000US6051722 Compounds, polymers, resin compositions and nonlinear optical devices
04/18/2000US6051721 Ring E-modified analogues of(-)-podophyllotoxin and etoposide and a method for their synthesis
04/18/2000US6051590 Useful as potassium channel inhibitors to treat autoimmune disorders
04/18/2000US6051565 Farnesyl-protein transferase inhibitors
04/13/2000WO2000020420A1 Derivatives of isosorbid mononitrate, utilization as vasodilator agents with reduced tolerance
04/13/2000WO2000020415A1 Phenylacetic acid heterocyclyl amides having an insecticidal effect
04/13/2000WO2000019999A1 Fulvic acid and its use in the treatment of various conditions
04/13/2000DE19846008A1 Phenylessigsäure-heterocyclylamide Phenylacetic acid heterocyclylamide
04/12/2000CN1051298C Substituted cyclohexanolester, its use for treatment of disease and pharmaceutical agent
04/11/2000US6049004 Oxidizing reactant selected form alcohols, esters, ethers, ketones, and aldehydes with nitric acid; mixing with solvent capable of extracting nitric acid from oxidation product to form pure organic acid
04/11/2000US6049000 Polymer coatings and effect paints for improvement of surfaces and aesthetic appearance of objects; handling, simplification
04/11/2000US6048986 Dehydration of difluoropyromellitic acid to form difluoropyromellitic dianhydride
04/11/2000US6048880 Therapy for cytokine sensitive diseases
04/11/2000US6048860 Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
04/11/2000US6048660 Non-volatile phenylglyoxalic esters
04/11/2000CA1340952C Chemiluminescent 1,2-dioxetane compounds
04/06/2000WO2000018755A1 Grey colouring photochromic fused pyrans
04/06/2000WO2000018747A1 Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders
04/06/2000WO2000018723A1 Substituted n-aliphatic-n-aromatic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
04/06/2000CA2345108A1 Substituted n-aliphatic-n-aromatic tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
04/05/2000EP0989857A1 Novel therapeutic agents that modulate enzymatic processes
04/05/2000CN1051082C Baccatine III derivs. and their preparation method
04/04/2000US6046342 3, 6-bis[4-(alkyloxy) phenyloxy] pyromellitic dianhydrides and process for preparing the same
04/04/2000US6046236 Carbocyclic sulfonamides
04/04/2000CA2078662C 4-desoxy-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof
03/2000
03/30/2000WO2000017206A1 Tetracyclic heterocycles as antimicrobial agents
03/29/2000EP0989137A2 Diagnostic agents for pancreatic exocrine function
03/29/2000EP0988301A1 Imidazolyl-cyclic acetals
03/29/2000EP0988060A2 Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy
03/29/2000CN1248974A Epothilones with a modified side chain
03/28/2000US6043382 Oxygenating the c13 deoxy carbon to form a c13 enone, then reducing the c13 enone to form a c13 alcohol, and then esterifying the c13 alcohol
03/28/2000US6043372 Intermediates in the process for preparing epothilones
03/28/2000US6043303 Hexagonal crystals of diacetals, nucleating agent comprising said hexagonal crystal, polyolefin resin composition and molding containing said hexagonal crystals, and method for molding said composition
03/28/2000US6043271 Method for the preparation of (±)-calanolide A and intermediates thereof
03/23/2000WO2000015631A1 Naphthopyrans annelated in c6-c7, their preparation and compositions and (co)polymer matrices containing them
03/23/2000WO2000015594A1 Process for making aromatic aldehydes using ionic liquids
03/23/2000WO2000015593A2 Process for making aromatic aldehydes
03/23/2000WO2000015044A1 Composition containing natural phenolic compounds for preventing or treating elevated blood lipid level-related diseases
03/23/2000CA2351548A1 Naphthopyrans annelated in c6-c7, their preparation and compositions and (co)polymer matrices containing them
03/23/2000CA2344401A1 Composition containing natural phenolic compounds for preventing or treating elevated blood lipid level-related diseases
03/23/2000CA2343400A1 Process for making aromatic aldehydes
03/23/2000CA2343309A1 Process for making aromatic aldehydes using ionic liquids
03/22/2000EP0987268A1 Epothilone A-N-oxide, epothilone B-N-oxide, process for their preparation and agent containing same
03/22/2000EP0987260A1 Photochromic spirofluorenopyrans
03/22/2000EP0987123A2 Erasable image forming material
03/22/2000EP0986381A1 Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment
03/22/2000EP0958514A4 Novel photochromic heterocyclic fused indenonaphthopyrans
03/22/2000EP0912908A4 Novel photochromic heterocyclic fused indenonaphthopyrans
03/22/2000CN1248245A Frangible compounds for pathogen inactivation
03/22/2000CN1248178A Method and device for production of small organic compounds from blood products
03/22/2000CN1248006A Imaging material capable of eliminating picture
03/22/2000CN1247858A Photoresist monomer, its copolymer and composition using the same
03/21/2000US6040308 Chroman derivatives